0,081€
0,93%
Echtzeit-Aktienkurs Starpharma Holdings Ltd.
Bid:
Ask:
Echtzeit-Chart der Starpharma Holdings Ltd. Aktie
Börsenkurse Starpharma Holdings Ltd.
Echtzeit Euro | - | - | - | - | 0,081€ | 1,00% |
Börse Stuttgart | - | - | - | - | 0,081€ | 8,00% |
gettex | - | - | - | - | 0,081€ | 0,00% |
Börse Frankfurt | - | - | - | - | 0,083€ | 12,24% |
Lang & Schwarz | - | - | - | - | 0,082€ | 1,24% |
Tradegate | - | - | - | - | 0,081€ | 0,93% |
Profil der Starpharma Holdings Ltd. Aktie
Starpharma Holdings Ltd. engages in the research and development of dendrimer products for pharmaceutical, life science and other applications. The firm's programs include: VivaGel portfolio, Drug delivery and Agrochemicals, which develops a number of products internally and others via commercial partnerships. Its product VivaGel, a gel-based formulation of a proprietary dendrimer and is under clinical development for the treatment and prevention of bacterial vaginosis and also as a vaginal microbicide to prevent the transmission of sexually transmitted infections including HIV and genital herpes. The company was founded in 1996 and is headquartered in Abbotsford, Australia.